/ /

ModernMedicine Resource Center More Topics

Video

Combination therapy seems best for relief of psoriasis

Combination therapy seems best for relief of psoriasis. Learn about which therapies work in the best combinations for your psoriasis patients.

Treatments for Plaque Psoriasis

Future technology could make psoriasis pills, injections obsoleteA novel cell-based strategy tested in mice can detect the onset of psoriasis flares by measuring disease biomarkers and then release therapeutic proteins to stop progression. Future implications are exciting.
What looks promising in the pipeline for psoriasisAs research advances understanding of psoriasis, drug development evolves to address various pathways to disease. A number of possibilities, now in clinical trials, appear safe, effective and promising with improved long-term clearance rates.
Cutaneous psoriasis, psoriatic arthritis genetic differences revealedResearchers have uncovered new information about the pathogenetic similarities and differences between cutaneous psoriasis and psoriatic arthritis in a recent study. They hope the information, one day, leads to a test to help doctors determine which psoriasis patients will advance with psoriatic disease.
A revolution in psoriasis careNewer medications have revolutionized psoriasis care in patients with moderate-to-severe cases, says a leading dermatologist, and more drugs in the pipeline promise to offer even more choices.
Indigo Naturalis
Indigo NaturalisIndigo naturalis is an Old-World plant with multiple uses. Used in China for centuries as a traditional medicine, current clinical studies are proving its effectiveness as well as identifying mechanisms of action.
Retinoids, vitamin D useful for hyperproliferative skin disorders
Retinoids, vitamin D useful for hyperproliferative skin disordersDermatologists could be making greater use of topical retinoids and vitamin D preparations in treating a variety of hyperproliferative and other skin disorders. In the early days of psoriasis treatment, the “sandwich theory” focused on epidermal turnover and inflammation, with one drug or strategy for each layer.
Off-label systemic immunomodulators useful for various indicationsAlthough many systemic immunomodulators are approved for psoriasis, their mechanisms of action suggest they have utility in indications ranging from atopic dermatitis (AD) to chronic urticaria. Understanding a systemic immunomodulator’s mechanism of action provides a theoretical basis for uses beyond its labeled indication.
Secukinumab approved for psoriasis
Secukinumab approved for psoriasisSecukinumab has received FDA approval as a new treatment option in psoriasis. A panel of experts tackles this drug’s uses, benefits, and drawbacks.
Oral options not keeping up with biologicsResearchers analyzed emerging oral drugs for psoriasis and concluded “… the development of new oral treatments for moderate-to-severe psoriasis has not kept pace with biologic therapies.
Study: CME improves psoriasis care
Study: CME improves psoriasis careNew Study suggests dermatologists completing a PI CME on psoriasis significantly improved in important patient care aspects. Learn more.